Long-term serological follow-up of blood donors with an HTLV-indeterminate western blot: Antibody profile of seroconverters and individuals with false reactions

Journal of Medical Virology

Volumn 82, Issue 10, 2010, Pages 1746-1753

  Martins, Marina Lobato ^a,b   Da Silva Santos, Ana Carolina ^a   Namen Lopes, Maria Sueli ^a,b   Barbosa Stancioli, Edel Figueiredo ^b,c   Utsch, Denise Gonçalves ^b,c   De Carneiro Proietti, Anna Bárbara F ^a,b  

^a FUNDAÇÃO HEMOMINAS   (Brazil)

^b GIPH   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Blood donors; False reactions; HTLV; Indeterminate; Seroconversion

Indexed keywords

GAG PROTEIN; PROTEIN P19;

ADULT; ARTICLE; BLOOD DONOR; ENZYME IMMUNOASSAY; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HUMAN; HUMAN T CELL LEUKEMIA VIRUS; HUMAN T CELL LEUKEMIA VIRUS 1; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; SEROCONVERSION; SEROLOGY; WESTERN BLOTTING;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; BLOOD DONORS; BLOTTING, WESTERN; FEMALE; FOLLOW-UP STUDIES; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; RETROVIRIDAE PROTEINS, ONCOGENIC; VIROLOGY; YOUNG ADULT;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 77956565740     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21881     Document Type: Article

References (29)

1. Allain J-P, Stramer SL, Carneiro-Proietti ABF, Martins ML, Lopes da Silva SN, Ribeiro M, Proietti FA, Reesink HW. 2009. Transfusion-transmitted infectious diseases. Biologicals 37:71-77.
2. Anthony RL, Jennings GB, Sie A, Ratiwayanto S, Bangs MJ. 1993. Prevalence of serum antibodies to human T lymphotropic virus-1 in an isolated tribe in the highlands of Irian Jaya, Indonesia Am J Trop Med 48:230-236.
3. Banki K, Maceda J, Hurley E, Ablonczy E, Mattson DH, Szegedy L, Hung C, Perl A. 1992. Human T-cell lymphotropic virus (HTLV)-related endogenous sequence, HRES-1, encodes a 28-kDa protein: A possible autoantigen for HTLV-I gag-reactive autoantibodies. Proc Natl Acad Sci USA 89:1939-1943.
4. Berini CA, Eirin ME, Pando MA, Biglione MM. 2007. Human T-cell lymphotropic virus types I and II (HTLV-I and -II) infection among seroindeterminate cases in Argentina. J Med Virol 79:69-73.
5. Busch MP, Switzer WM, Murphy EL, Thomson R, Heneine W. 2000. Absence of evidence of infection with divergent primate T-lymphotropic viruses in United States blood donors who have seroindeterminate HTLV test results. Transfusion 40:443-449.
6. Catalan-Soares B, Carneiro-Proietti ABF, Proietti FA. 2005. Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV-I/II): Serological screening prevalence rates in blood donors from large urban areas in Brazil. Cad Saude Publica 21:926-931.
7. Césaire R, Bera O, Maier H, Lezin A, Martial J, Ouka M, Kerob-Bauchet B, Ould Amar AK, Vernant JC. 1999. Seroindeterminate patterns and seroconversions to human T-lymphotropic virus type I positivity in blood donors from Martinique, French West Indies. Transfusion 39:1145-1149.
8. Davidson F, Lycett C, Jarvis LM, Kerr D, Lumley S, Petrik J, Dow BC. 2006. Detection of HTLV-I and -II in Scottish blood donor samples and archive donations. Vox Sang 91:231-236.
9. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A, de The G. 1985. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 2:407-410.
10. Hayes G, Burans JP, Oberst RB. 1991. Antibodies to human T lymphotropic virus type I in a population from the Philippines evidence for cross-reactivity with Plasmodium falciparum. J Infect Dis 163:257-262.
11. Jacob F, Santos-Fortuna E, Azevedo RS, Caterino-de-Araújo A. 2007. Performances of HTLV serological tests in diagnosing HTLV infection in high-risk population of São Paulo, Brazil. Rev Inst Med Trop S Paulo 49:361-364.
12. Khabbaz RF, Heneine W, Grindon A, Hartley TM, Shulman G, Kaplan J. 1992. Indeterminate HTLV serologic results in U.S. blood donors: Are they due to HTLV-I or HTLV-II? J Acquir Immune Defic Syndr 5:400-404.
13. LaGrenade L, Hanchard B, Fletcher V, Cranston B, Blattner W. 1990. Infective dermatitis of Jamaican children: A marker for HTLV-I infection. Lancet 336:1345-1347.
14. Lal RB, Rudolph DL, Coligan JE, Brodine SK, Roberts CR. 1992a. Failure to detect evidence of human T-lymphotropic virus (HTLV) type I and type II in blood donors with isolated gag antibodies to HTLV-I/II. Blood 80:544-550.
15. Lal RB, Rudolph DL, Nerurkar VR, Yanagihara R. 1992b. Humoral responses to the immunodominant gag and env epitopes of human T-lymphotropic virus type I among Melanesians. Viral Immunol 5:265-272.
16. Lu SC, Chen BH. 2003. Seroindeterminate HTLV-1 prevalence and charateristics in blood donors in Taiwan. Int J Hematol 77:412-413.
17. Mahieux R, Horal P, Mauclère P, Mercereau-Puijalon O, Guillotte M, Meertens L, Murphy E, Gessain A. 2000. Human T-cell lymphotropic virus type 1 gag indeterminate western blot patterns in Central Africa: Relationship to Plasmodium falciparum infection. J Clin Microbiol 38:4049-4057.
18. Mauclère P, Le Hesran JY, Mahieux R, Salla R, Mfoupouendoun J, Abada ET, Millan J, de Thé G, Gessain A. 1997. Demographic, ethnic, and geographic differences between human T cell lymphotropic virus (HTLV) type I-seropositive carriers and persons with HTLV-I Gag-indeterminate Western blots in Central Africa. J Infect Dis 176:505-509.
19. Mochizuki M, Watanabe T, Yamaguchi K, Takatsuki K, Yoshimura K, Shirao M, Nakashima S, Mori S, Araki S, Miyata N. 1992. HTLV-I uveitis: A distinct clinical entity caused by HTLV-I. Jpn J Cancer Res 5:29-42.
20. Nerurkar VR, Miller MA, Leon-Monzon ME, Ajdukiewicz AB, Jenkins CL, Sanders RC, Godec MS, Garruto RM, Yanagihara R. 1992. Failure to isolate human T cell lymphotropic virus type I and to detect variant-specific genomic sequences by polymerase chain reaction in Melanesians with indeterminate western immunoblot. J Gen Virol 73:1805-1810.
21. Nishioka K, Maruyama I, Sato K, Kitajima I, Nakajima Y, Osame M. 1989. Chronic inflammatory arthropathy associated with HTLV-I. Lancet 1:441.
22. Nobre V, Guedes AC, Martins ML, Barbosa-Stancioli EF, Serufo JC, Proietti FA, Ribas JG, Ferreira CE, Lambertucci JR, GIPH Interdisciplinary Group on HTLV-1/2 Research. 2006. Dermatological findings in 3 generations of a family with a high prevalence of human T cell lymphotropic virus type 1 infection in Brazil. Clin Infect Dis 43:1257-1263.
23. Nogueira CM, Cavalcanti M, Schechter M, Ferreira OC, Jr. 1996. Human T lymphotropic virus type I and II infections in healthy blood donors from Rio de Janeiro, Brazil. Vox Sang 70:47-48.
24. Proietti FA, Lima-Martins MV, Passos VM, Brener S, Carneiro-Proietti AB. 1994. HTLV-I/II seropositivity among eligible blood donors from Minas Gerais State, Brasil. Vox Sang 67:77.
25. Proietti FA, Carneiro-Proietti ABF, Catalan-Soares BC, Murphy EL. 2005. Global epidemiology of HTLV-I infection and associated diseases. Oncogene 24:6058-6068.
26. Rouet F, Meetens L, Courouble G, Herrmann-Storck C, Pabingui R, Chancerel B, Abid A, Strobel M, Mauclere P, Gessain A. 2001. Serological, epidemiological, and molecular difference between human T cell lymphotropic virus type 1 (HTLV-I)-seropositive healthy carriers and persons with HTLV-I Gag indeterminate Western blot patterns from Caribbean. J Clin Microbiol 39:1247-1253.
27. Seed CR, Margaritis AR, Bolton WV, Kiely P, Parker S, Piscitelli L, Virology Subcommittee of the National Donor and Product Safety Committee, Australian Red Cross Blood Service. 2003. Improved efficiency of national HIV, HCV, and HTLV antibody testing algorithms based on sequential screening immunoassays. Transfusion 43:226-234.
28. Thorstensson R, Albert J, Andersson S. 2002. Strategies for diagnosis of HTLV-I and HTLV-II. Transfusion 42:780-791.
29. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino H. 1977. Adult T-cell leukemia: Clinical and hematologic features of 16 cases. Blood 50:481-492.